Trials / Completed
CompletedNCT02001584
A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Gedeon Richter Plc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of a predefined dose range of co-administered Baclofen and Memantine in non-obese (Part A) and obese (Part B), otherwise healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Baclofen | |
| DRUG | Memantine | |
| DRUG | Placebo |
Timeline
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2013-12-05
- Last updated
- 2014-07-08
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02001584. Inclusion in this directory is not an endorsement.